Clinical Trial Update: A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD. [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 clinical trial evaluating AC-003 capsules for acute graft-versus-host disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• AC-003 capsules (AC-003)

Snippet

Sponsor: Accro Bioscience (Suzhou) Limited | Conditions: Acute Graft-versus-Host Disease | Phase 1 | Status: RECRUITING